Trial Information

Summary: Fibromyalgia

Phase III randomized, double-blind, placebo controlled study to evaluate the safety and efficacy of Reboxetine in alleviating pain and fatigue of Fibromyalgia.There is a possibility of entering an open-label extension. This study consists of 14 weeks with 8 office visits and you will be compensated for your time and travel upon completion of the study.

Patient Inclusion Criteria:
  • Male or female 18 or older
  • Female patients must not be pregnant and taking 2 forms of accepted birth control
  • Wide spread pain for at least 3 months and in at least 11 of 18 specific tender points

Patient Exclusion Criteria:

  • Patients with other severe pain that may confound assessment or self-evaluation
  • Patients with any other autoimmune disorder, or active infection
  • History of seizure disorder
  • History of uncontrolled glaucoma
  • Patients with history of TIA,stroke, or presence of carotid bruit
  • Hepatitis within the last 3 months or HIV
  • History of urinary retention

Contact:

Renstar Medical Research
104 SE 1st Ave
Ocala, FL 34471
Telephone: 352-629-5800 or 877-629-5800
Email:

Profile Page: Renstar Medical Research, Ocala, FL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:44:20 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA